nach oben

Erschienen in:

05.04.2017 | Review

Cholinergic urticaria: epidemiology, physiopathology, new categorization, and management

verfasst von: Atsushi Fukunaga, Ken Washio, Mayumi Hatakeyama, Yoshiko Oda, Kanako Ogura, Tatsuya Horikawa, Chikako Nishigori

Erschienen in: Clinical Autonomic Research | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study was to review the evidence on the epidemiology, physiopathology, categorization, and management of cholinergic urticaria. We specifically focused on several subtypes of cholinergic urticaria and investigated the relationship between cholinergic urticaria and idiopathic anhidrosis.

Methods

Using an integrative approach, we reviewed publications addressing the epidemiology, clinical features, diagnostic approach, physiopathology, subtype classification, and therapeutic approach to cholinergic urticaria.

Results

Multiple mechanisms were found to contribute to the development of cholinergic urticaria. This disorder should be classified based on the pathogenesis and clinical characteristics of each subtype. Such a classification system would lead to better management of this resistant condition. In particular, sweating function should be given more attention when examining patients with cholinergic urticaria.

Conclusions

Because cholinergic urticaria is not a homogeneous disease, its subtype classification is essential for selection of the most suitable therapeutic method.

Ww D (1924) Urticaria caused specifically by the action of physical agents. J Am Med Assoc 83:3–9CrossRef

Hirschmann JV, Lawlor F, English JS, Louback JB, Winkelmann RK, Greaves MW (1987) Cholinergic urticaria. A clinical and histologic study. Arch Dermatol 123:462–467CrossRefPubMed

Moore-Robinson M, Warin RP (1968) Some clinical aspects of cholinergic urticaria. Br J Dermatol 80:794–799CrossRefPubMed

Hatakeyama M, Fukunaga A, Washio K, Ogura K, Yamada Y, Horikawa T, Nishigori C (2016) Addition of lafutidine can improve disease activity and lead to better quality of life in refractory cholinergic urticaria unresponsive to histamine H1 antagonists. J Dermatol Sci 82:137–139CrossRefPubMed

Sawada Y, Nakamura M, Bito T, Fukamachi S, Kabashima R, Sugita K, Hino R, Tokura Y (2010) Cholinergic urticaria: studies on the muscarinic cholinergic receptor M3 in anhidrotic and hypohidrotic skin. J Invest Dermatol 130:2683–2686CrossRefPubMed

Kaplan AP, Garofalo J (1981) Identification of a new physically induced urticaria: cold-induced cholinergic urticaria. J Allergy Clin Immunol 68:438–441CrossRefPubMed

Lawrence CM, Jorizzo JL, Kobza-Black A, Coutts A, Greaves MW (1981) Cholinergic urticaria with associated angio-oedema. Br J Dermatol 105:543–550CrossRefPubMed

Vadas P, Sinilaite A, Chaim M (2016) Cholinergic urticaria with anaphylaxis: an underrecognized clinical entity. J Allergy Clin Immunol Pract 4:284–291CrossRefPubMed

Horikawa T, Fukunaga A, Nishigori C (2009) New concepts of hive formation in cholinergic urticaria. Curr Allergy Asthma Rep 9:273–279CrossRefPubMed

10.

Nakamizo S, Egawa G, Miyachi Y, Kabashima K (2012) Cholinergic urticaria: pathogenesis-based categorization and its treatment options. J Eur Acad Dermatol Venereol 26:114–116CrossRefPubMed

11.

Zuberbier T, Althaus C, Chantraine-Hess S, Czarnetzki BM (1994) Prevalence of cholinergic urticaria in young adults. J Am Acad Dermatol 31:978–981CrossRefPubMed

12.

Bito T, Sawada Y, Tokura Y (2012) Pathogenesis of cholinergic urticaria in relation to sweating. Allergol Int 61:539–544CrossRefPubMed

13.

Washio K, Fukunaga A, Onodera M, Hatakeyama M, Taguchi K, Ogura K, Horikawa T, Nishigori C (2017) Clinical characteristics in cholinergic urticaria with palpebral angioedema: report of 15 cases. J Dermatol Sci 85:135–137CrossRefPubMed

14.

Fukunaga A, Bito T, Tsuru K, Oohashi A, Yu X, Ichihashi M, Nishigori C, Horikawa T (2005) Responsiveness to autologous sweat and serum in cholinergic urticaria classifies its clinical subtypes. J Allergy Clin Immunol 116:397–402CrossRefPubMed

15.

Sawada Y, Nakamura M, Bito T, Sakabe J, Kabashima-Kubo R, Hino R, Kobayashi M, Tokura Y (2014) Decreased expression of acetylcholine esterase in cholinergic urticaria with hypohidrosis or anhidrosis. J Invest Dermatol 134:276–279CrossRefPubMed

16.

Fukunaga A, Hatakeyama M, Tsujimoto M, Oda Y, Washio K, Nishigori C (2015) Steroid treatment can improve the impaired quality of life of patients with acquired idiopathic generalized anhidrosis. Br J Dermatol 172:537–538CrossRefPubMed

17.

Magerl M, Altrichter S, Borzova E, Gimenez-Arnau A, Grattan CE, Lawlor F, Mathelier-Fusade P, Meshkova RY, Zuberbier T, Metz M, Maurer M (2016) The definition, diagnostic testing, and management of chronic inducible urticarias—the EAACI/GA(2) LEN/EDF/UNEV consensus recommendations 2016 update and revision. Allergy 71:780–802CrossRefPubMed

18.

Bernstein JA, Lang DM, Khan DA, Craig T, Dreyfus D, Hsieh F, Sheikh J, Weldon D, Zuraw B, Bernstein DI, Blessing-Moore J, Cox L, Nicklas RA, Oppenheimer J, Portnoy JM, Randolph CR, Schuller DE, Spector SL, Tilles SA, Wallace D (2014) The diagnosis and management of acute and chronic urticaria: 2014 update. J Allergy Clin Immunol 133:1270–1277CrossRefPubMed

19.

Hide M, Hiragun T, Japanese Dermatological A (2012) Japanese guidelines for diagnosis and treatment of urticaria in comparison with other countries. Allergol Int 61:517–527CrossRefPubMed

20.

Shoenfeld Y, Harari Z, Sheonfeld Y, Keren G (1981) Cholinergic urticaria. A seasonal disease. Arch Intern Med 141:1029–1030CrossRefPubMed

21.

Godse K, Farooqui S, Nadkarni N, Patil S (2013) Prevalence of cholinergic urticaria in Indian adults. Indian Dermatol Online J 4:62–63CrossRefPubMedPubMedCentral

22.

Takahagi S, Tanaka T, Ishii K, Suzuki H, Kameyoshi Y, Shindo H, Hide M (2009) Sweat antigen induces histamine release from basophils of patients with cholinergic urticaria associated with atopic diathesis. Br J Dermatol 160:426–428CrossRefPubMed

23.

Altrichter S, Koch K, Church MK, Maurer M (2016) Atopic predisposition in cholinergic urticaria patients and its implications. J Eur Acad Dermatol Venereol 30:2060–2065CrossRefPubMed

24.

Magerl M, Borzova E, Gimenez-Arnau A, Grattan CE, Lawlor F, Mathelier-Fusade P, Metz M, Mlynek A, Maurer M, Eaaci/Ga2Len/Edf/Unev (2009) The definition and diagnostic testing of physical and cholinergic urticarias–EAACI/GA2LEN/EDF/UNEV consensus panel recommendations. Allergy 64:1715–1721CrossRefPubMed

25.

Illig L, Paul E, Bruck K, Schwennicke HP (1980) Experimental investigations on the trigger mechanism of the generalized type of heat and cold urticaria by means of a climatic chamber. Acta Derm Venereol 60:373–380PubMed

26.

Commens CA, Greaves MW (1978) Tests to establish the diagnosis in cholinergic urticaria. Br J Dermatol 98:47–51CrossRefPubMed

27.

Altrichter S, Salow J, Ardelean E, Church MK, Werner A, Maurer M (2014) Development of a standardized pulse-controlled ergometry test for diagnosing and investigating cholinergic urticaria. J Dermatol Sci 75:88–93CrossRefPubMed

28.

Oda Y, Fukunaga A, Tsujimoto M, Hatakeyama M, Washio K, Nishigori C (2015) Combined cholinergic urticaria and cold-induced cholinergic urticaria with acquired idiopathic generalized anhidrosis. Allergol Int 64:214–215CrossRefPubMed

29.

Fukunaga A, Shimizu H, Tanaka M, Kikuzawa A, Tsujimoto M, Sekimukai A, Yamashita J, Horikawa T, Nishigori C (2012) Limited influence of aspirin intake on mast cell activation in patients with food-dependent exercise-induced anaphylaxis: comparison using skin prick and histamine release tests. Acta Derm Venereol 92:480–483CrossRefPubMed

30.

Pezzolo E, Peroni A, Gisondi P, Girolomoni G (2016) Heat urticaria: a revision of published cases with an update on classification and management. Br J Dermatol 175:473–478CrossRefPubMed

31.

Fukunaga A, Shimoura S, Fukunaga M, Ueda M, Nagai H, Bito T, Tsuru K, Ichihashi M, Horikawa T (2002) Localized heat urticaria in a patient is associated with a wealing response to heated autologous serum. Br J Dermatol 147:994–997CrossRefPubMed

32.

Luong KV, Nguyen LT (1998) Aquagenic urticaria: report of a case and review of the literature. Ann Allergy Asthma Immunol 80:483–485CrossRefPubMed

33.

Shelley WB, Shelley ED (1985) Adrenergic urticaria: a new form of stress-induced hives. Lancet 2:1031–1033CrossRefPubMed

34.

Chedraoui A, Uthman I, Abbas O, Ghosn S (2008) Adrenergic urticaria in a patient with anti-double-stranded DNA antibodies. Acta Derm Venereol 88:263–266PubMed

35.

Kawakami Y, Gokita M, Fukunaga A, Nishigori C (2015) Refractory case of adrenergic urticaria successfully treated with clotiazepam. J Dermatol 42:635–637CrossRefPubMed

36.

Soter NA, Wasserman SI, Austen KF, McFadden ER Jr (1980) Release of mast-cell mediators and alterations in lung function in patients with cholinergic urticaria. N Engl J Med 302:604–608CrossRefPubMed

37.

Kaplan AP, Gray L, Shaff RE, Horakova Z, Beaven MA (1975) In vivo studies of mediator release in cold urticaria and cholinergic urticaria. J Allergy Clin Immunol 55:394–402CrossRefPubMed

38.

Nakazato Y, Tamura N, Ohkuma A, Yoshimaru K, Shimazu K (2004) Idiopathic pure sudomotor failure: anhidrosis due to deficits in cholinergic transmission. Neurology 63:1476–1480CrossRefPubMed

39.

Kobayashi H, Aiba S, Yamagishi T, Tanita M, Hara M, Saito H, Tagami H (2002) Cholinergic urticaria, a new pathogenic concept: hypohidrosis due to interference with the delivery of sweat to the skin surface. Dermatology 204:173–178CrossRefPubMed

40.

Soter NA, Wasserman SI (1980) Physical urticaria/angioedema: an experimental model of mast cell activation in humans. J Allergy Clin Immunol 66:358–365CrossRefPubMed

41.

Koch K, Weller K, Werner A, Maurer M, Altrichter S (2016) Antihistamine updosing reduces disease activity in patients with difficult-to-treat cholinergic urticaria. J Allergy Clin Immunol 138(1483–1485):e1489

42.

Adachi J, Aoki T, Yamatodani A (1994) Demonstration of sweat allergy in cholinergic urticaria. J Dermatol Sci 7:142–149CrossRefPubMed

43.

Kozaru T, Fukunaga A, Taguchi K, Ogura K, Nagano T, Oka M, Horikawa T, Nishigori C (2011) Rapid desensitization with autologous sweat in cholinergic urticaria. Allergol Int 60:277–281CrossRefPubMed

44.

Hiragun T, Hide M (2016) Sweat Allergy. Curr Probl Dermatol 51:101–108CrossRefPubMed

45.

Hiragun T, Ishii K, Hiragun M, Suzuki H, Kan T, Mihara S, Yanase Y, Bartels J, Schroder JM, Hide M (2013) Fungal protein MGL_1304 in sweat is an allergen for atopic dermatitis patients. J Allergy Clin Immunol 132(608–615):e604

46.

Hiragun M, Hiragun T, Ishii K, Suzuki H, Tanaka A, Yanase Y, Mihara S, Haruta Y, Kohno N, Hide M (2014) Elevated serum IgE against MGL_1304 in patients with atopic dermatitis and cholinergic urticaria. Allergol Int 63:83–93CrossRefPubMed

47.

Hide M, Francis DM, Grattan CE, Hakimi J, Kochan JP, Greaves MW (1993) Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 328:1599–1604CrossRefPubMed

48.

Sabroe RA, Grattan CE, Francis DM, Barr RM, Kobza Black A, Greaves MW (1999) The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 140:446–452CrossRefPubMed

49.

Kim JE, Jung KH, Cho HH, Kang H, Park YM, Park HJ, Lee JY (2015) The significance of hypersensitivity to autologous sweat and serum in cholinergic urticaria: cholinergic urticaria may have different subtypes. Int J Dermatol 54:771–777CrossRefPubMed

50.

Rho NK (2006) Cholinergic urticaria and hypohidrosis: a clinical reappraisal. Dermatology 213:357–358CrossRefPubMed

51.

Fukunaga A, Horikawa T, Sato M, Nishigori C (2009) Acquired idiopathic generalized anhidrosis: possible pathogenic role of mast cells. Br J Dermatol 160:1337–1340CrossRefPubMed

52.

Itakura E, Urabe K, Yasumoto S, Nakayama J, Furue M (2000) Cholinergic urticaria associated with acquired generalized hypohidrosis: report of a case and review of the literature. Br J Dermatol 143:1064–1066CrossRefPubMed

53.

Nakamizo S, Miyachi Y, Kabashima K (2010) A case of cholinergic urticaria associated with acquired generalized hypohidrosis and abnormal neurological findings: association with incomplete Ross syndrome? Br J Dermatol 162:903–905CrossRefPubMed

54.

Shelley WB, Shelley ED, Ho AK (1983) Cholinergic urticaria: acetylcholine-receptor-dependent immediate-type hypersensitivity reaction to copper. Lancet 1:843–846CrossRefPubMed

55.

Munetsugu T, Fujimoto T, Oshima Y, Sano K, Murota H, Satoh T, Iwase S, Asahina M, Nakazato Y, Yokozeki H (2016) Revised guideline for the diagnosis and treatment of acquired idiopathic generalized anhidrosis in Japan. J Dermatol. doi:10.1111/1346-8138.13649

56.

Shelley WB, Rawnsley HM (1964) Aquagenic urticaria. Contact sensitivity reaction to water. JAMA 189:895–898PubMed

57.

Shelley WB, Shelley ED (1983) Follicular dermographism. Cutis 32:244–245, 254, 260PubMed

58.

Nakazato Y, Tamura N, Ikeda K, Yamamoto T, Tokura Y (2016) A case of idiopathic pure sudomotor failure associated with prolonged high levels of serum carcinoembryonic antigen. Clin Auton Res 26:451–453CrossRefPubMed

59.

Zuberbier T, Munzberger C, Haustein U, Trippas E, Burtin B, Mariz SD, Henz BM (1996) Double-blind crossover study of high-dose cetirizine in cholinergic urticaria. Dermatology 193:324–327CrossRefPubMed

60.

Tsunemi Y, Ihn H, Saeki H, Tamaki K (2003) Cholinergic urticaria successfully treated with scopolamine butylbromide. Int J Dermatol 42:850CrossRefPubMed

61.

Feinberg JH, Toner CB (2008) Successful treatment of disabling cholinergic urticaria. Mil Med 173:217–220CrossRefPubMed

62.

Sheraz A, Halpern S (2013) Cholinergic urticaria responding to botulinum toxin injection for axillary hyperhidrosis. Br J Dermatol 168:1369–1370CrossRefPubMed

63.

Metz M, Ohanyan T, Church MK, Maurer M (2014) Retreatment with omalizumab results in rapid remission in chronic spontaneous and inducible urticaria. JAMA Dermatol 150:288–290CrossRefPubMed

64.

Metz M, Bergmann P, Zuberbier T, Maurer M (2008) Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy. Allergy 63:247–249CrossRefPubMed

65.

Sabroe RA (2010) Failure of omalizumab in cholinergic urticaria. Clin Exp Dermatol 35:e127–e129

66.

Ohshima Y, Yanagishita T, Ito K, Tamada Y, Nishimura N, Inukai Y, Iwase S, Sugenoya J, Watanabe D (2013) Treatment of patients with acquired idiopathic generalized anhidrosis. Br J Dermatol 168:430–432CrossRefPubMed

67.

Suma A, Murota H, Kitaba S, Yamaoka T, Kato K, Matsui S, Takahashi A, Yokomi A, Katayama I (2014) Idiopathic pure sudomotor failure responding to oral antihistamine with sweating activities. Acta Derm Venereol 94:723–724CrossRefPubMed

Titel: Cholinergic urticaria: epidemiology, physiopathology, new categorization, and management
verfasst von: Atsushi Fukunaga
Ken Washio
Mayumi Hatakeyama
Yoshiko Oda
Kanako Ogura
Tatsuya Horikawa
Chikako Nishigori
Publikationsdatum: 05.04.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: Clinical Autonomic Research / Ausgabe 1/2018
Print ISSN: 0959-9851
Elektronische ISSN: 1619-1560
DOI: https://doi.org/10.1007/s10286-017-0418-6

Neu in den Fachgebieten Neurologie und Psychiatrie

23.04.2024 | Demenz | Nachrichten

Springer Medizin

Cholinergic urticaria: epidemiology, physiopathology, new categorization, and management

Abstract

Purpose

Methods

Results

Conclusions

Neu in den Fachgebieten Neurologie und Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2018

Seronegative autoimmune autonomic neuropathy: a distinct clinical entity

Autonomic dysfunction predicts poor outcome in stroke: Updates on recent autonomic research

Autoimmune autonomic neuropathies: time to look beyond autoimmune autonomic ganglionopathy

Metoprolol, propranolol, carvedilol, or labetalol for patients with Takotsubo syndrome?

Reply to: metoprolol, or propranolol, or carvedilol, or labetalol, for patients with takotsubo syndrome?

Neurogenic dysphagia with undigested macaroni and megaesophagus in familial dysautonomia

Neu in den Fachgebieten Neurologie und Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein